Amy Wilson is currently the Director of Genetic Toxicology at AstraZeneca, having previously served as the Program Manager for the Cambridge Alliance on Medicines Safety (CAMS). Amy joined AstraZeneca in 2016 as a Senior Scientist, providing essential GeneTox support across various projects. They completed their undergraduate studies in Biochemistry at the University of Liverpool and earned a PhD from King's College London, focusing on novel proteins involved in cytokinesis. They have a keen interest in developing innovative genetic toxicology assays and utilizing advanced imaging and machine learning techniques.
This person is not in the org chart
This person is not in any teams
This person is not in any offices